ArticleCardiovascular diabetology2025

Comparative cardiovascular outcomes and safety of hypoglycemic drug classes in patients with type 2 diabetes and hypertension: a multicenter cohort analysis.

Zhiyuan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.